Ralph Santos‐Oliveira

ORCID: 0000-0002-7221-6404 · 3 papers in corpus
lab-animal 2026
Arimoclomol-loaded Pluronic F127 nanomicelles in experimental endometriosis: drug incorporation, in vitro release, and early morphological and histological responses
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V ·doi:10.1016/j.ejpb.2026.115237

Endometriosis is a chronic, estrogen-dependent inflammatory disease characterized by ectopic endometrial-like glands and stroma, persistent pelvic inflammation, pain, infertility, and frequent recurrence. The limited availability of nonhorm…

2017
Development and Application of a Nanoradiopharmaceutical Based on the Monoclonal Antibody Bevacizumab for Endometriosis: Comparison Between Normal and Nanoparticulate Monoclonal Antibody as Imaging Radiopharmaceutical
·doi:10.1166/asem.2017.2074
lab-animal 2015
Developing a Noninvasive Procedure Using Labeled Monoclonal Antibody Anti-VEGF (Bevacizumab) for Detection of Endometriosis
BioMed research international ·doi:10.1155/2015/751460

The off-label use of bevacizumab labeled with 99mTc as a new radiopharmaceutical for imaging of endometriosis is a promising noninvasive, new clinical procedure. The bevacizumab in monoclonal antibodies targeted at vascular endothelial grow…